chr3-53089257-A-G

Position:

• chr3-53089257-A-G

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_Strong BP6_Very_Strong BA1

The NM_052859.4(RFT1):​c.*2646T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.485 in 152,460 control chromosomes in the GnomAD database, including 19,855 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

• Frequency:
  • Genomes: 𝑓 0.49 (19777 hom., cov: 31)
  • Exomes 𝑓: 0.64 (78 hom.)
• Consequence: RFT1 NM_052859.4 3_prime_UTR
• Clinical Significance: Benign criteria provided, multiple submitters, no conflicts B:2
• Conservation: PhyloP100: -0.213

Genes affected

RFT1 (HGNC:30220): (RFT1 homolog) This gene encodes an enzyme which catalyzes the translocation of the Man(5)GlcNAc (2)-PP-Dol intermediate from the cytoplasmic to the luminal side of the endoplasmic reticulum membrane in the pathway for the N-glycosylation of proteins. Mutations in this gene are associated with congenital disorder of glycosylation type In.[provided by RefSeq, Dec 2008]

ACMG classification

Verdict is Benign. Variant got -20 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.98).
• BP6: Variant 3-53089257-A-G is Benign according to our data. Variant chr3-53089257-A-G is described in ClinVar as [Benign]. Clinvar id is 346149.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
• BA1: GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.708 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
RFT1	NM_052859.4	c.*2646T>C		3_prime_UTR_variant	13/13	ENST00000296292.8	NP_443091.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
RFT1	ENST00000296292.8	c.*2646T>C		3_prime_UTR_variant	13/13	1	NM_052859.4	ENSP00000296292	P1

Frequencies

GnomAD3 genomes AF: 0.485 AC: 73729 AN: 151942 Hom.: 19771 Cov.: 31

Gnomad AFR AF: 0.244

Gnomad AMI AF: 0.732

Gnomad AMR AF: 0.576

Gnomad ASJ AF: 0.645

Gnomad EAS AF: 0.728

Gnomad SAS AF: 0.495

Gnomad FIN AF: 0.585

Gnomad MID AF: 0.487

Gnomad NFE AF: 0.564

Gnomad OTH AF: 0.521

GnomAD4 exome AF: 0.640 AC: 256 AN: 400 Hom.: 78 Cov.: 0 AF XY: 0.629 AC XY: 200 AN XY: 318

Gnomad4 AFR exome AF: 0.333

Gnomad4 AMR exome AF: 1.00

Gnomad4 ASJ exome AF: 0.750

Gnomad4 EAS exome AF: 0.688

Gnomad4 SAS exome AF: 0.250

Gnomad4 FIN exome AF: 0.583

Gnomad4 NFE exome AF: 0.659

Gnomad4 OTH exome AF: 0.577

GnomAD4 genome AF: 0.485 AC: 73762 AN: 152060 Hom.: 19777 Cov.: 31 AF XY: 0.489 AC XY: 36318 AN XY: 74310

Gnomad4 AFR AF: 0.245

Gnomad4 AMR AF: 0.577

Gnomad4 ASJ AF: 0.645

Gnomad4 EAS AF: 0.728

Gnomad4 SAS AF: 0.494

Gnomad4 FIN AF: 0.585

Gnomad4 NFE AF: 0.564

Gnomad4 OTH AF: 0.520

Alfa AF: 0.549 Hom.: 14126

Bravo AF: 0.480

Asia WGS AF: 0.607 AC: 2108 AN: 3478

ClinVar

Significance: Benign

Submissions summary: Benign:2

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

RFT1-congenital disorder of glycosylation Benign:1

Benign, criteria provided, single submitter

clinical testing

Illumina Laboratory Services, Illumina

Jan 13, 2018

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1

Benign, criteria provided, single submitter

not provided

Breakthrough Genomics, Breakthrough Genomics

-

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.98
CADD	Benign	1.5
DANN	Benign	0.40

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs891368; hg19: chr3-53123273;